# Satellos Bioscience Inc.: Form 40-F for the period ended Dec 31, 2025

- Company: [Satellos Bioscience Inc.](/companies/msle.md) (CIK 1421642)
- Form: 40-F
- Filed: 2026-03-27
- Accepted by EDGAR: Mar 27, 2026, 08:24 ET
- Period: 2025-12-31
- Accession: 0001104659-26-035729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1421642/000110465926035729/msle-20251231x40f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1421642/000110465926035729/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | −$26.5m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $172.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$24.9m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | −$1.70 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | −$1.70 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | −$23.6m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $6.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2025-12-31 | $9.8m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2025-12-31 | $31.9m | ifrs-full:CurrentAssets |
| Total assets | at 2025-12-31 | $31.9m | ifrs-full:Assets |
| Current liabilities | at 2025-12-31 | $4.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2025-12-31 | $4.1m | ifrs-full:Liabilities |
| Shareholders' equity | at 2025-12-31 | $27.8m | ifrs-full:Equity |
| Shares outstanding | at 2025-12-31 | 15,458,903 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1421642/000110465926035729/msle-20251231x40f.htm

Filed Mar 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-035729. Last ingested by Listed: Nov 12, 2026, 17:42 ET. No prices; not investment advice.